Bunge executive granted 171 BG restricted stock units

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Bunge Global SA executive vice president and chief sustainability officer Christos Dimopoulos acquired 171 shares of common stock on March 3, 2026 through a grant classified as a “grant, award, or other acquisition.” A footnote explains these represent restricted stock units credited via a dividend feature under the company’s long-term incentive plans. Following this award, Dimopoulos held a total of 104,914.808 shares of Bunge Global SA common stock in direct ownership.

Insider Trade Summary

Grant/Award: 171 shares

Grant/Award 1 txn

Insider Dimopoulos Christos

Role EVP and CSO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	171	$116.83	$20K

Holdings After Transaction: Common Stock — 104,914.808 shares (Direct)

Footnotes (1)

F1. Represents restricted stock units acquired on March 3, 2026 pursuant to a dividend feature under the registrant's long-term incentive plans.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bunge Global SA (BG) report for Christos Dimopoulos?

Bunge Global SA reported that executive vice president and chief sustainability officer Christos Dimopoulos acquired 171 shares of common stock. The acquisition was recorded as a grant or award under the company’s compensation plans, rather than an open-market purchase or sale.

How many Bunge Global SA shares does Christos Dimopoulos hold after this Form 4 transaction?

After the reported transaction, Christos Dimopoulos held a total of 104,914.808 shares of Bunge Global SA common stock. This figure reflects his direct ownership position immediately following the March 3, 2026 restricted stock unit grant credited via the dividend feature.

What is the nature of the 171 Bunge Global SA shares acquired by Christos Dimopoulos?

The 171 shares are linked to restricted stock units acquired on March 3, 2026. A footnote states they were credited pursuant to a dividend feature under Bunge Global SA’s long‑term incentive plans, indicating they are part of an equity compensation arrangement.

Was the Bunge Global SA Form 4 transaction a market purchase or sale of BG stock?

The Form 4 describes the transaction as a grant, award, or other acquisition, not a market trade. It reflects restricted stock units credited through a dividend feature under long‑term incentive plans, rather than an open‑market buy or sell of Bunge Global SA shares.

How is ownership type characterized for Christos Dimopoulos in this Bunge Global SA Form 4?

The filing classifies Christos Dimopoulos’s ownership of the reported Bunge Global SA common stock as direct. The transaction is marked with ownership code “D,” and there is no indication in the footnotes of any intermediary entity or disclaimer of beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/05/2026 - 05:03 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dimopoulos Christos

(Last)

(First)

(Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD

63017

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP and CSO

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2026		A		171⁽¹⁾	A	$116.83	104,914.808	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units acquired on March 3, 2026 pursuant to a dividend feature under the registrant's long-term incentive plans.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR